te-031 was administered orally to 5 patients with mycoplasma pneumonia , 21 patients with pneumonia or bronchopneumonia , 2 patients with pertussis and 2 patients with enterocolitis at daily dosages ranging 11.1-31.6 mg/kg divided into 3 .
C0032285
pneumonia
C0006285
bronchopneumonia